Technical Analysis for FLXN - Flexion Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 21.93 0.09% 0.02
FLXN closed up 0.09 percent on Friday, August 17, 2018, on 75 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical FLXN trend table...

Date Alert Name Type % Chg
Aug 17 NR7 Range Contraction 0.00%
Aug 17 Inside Day Range Contraction 0.00%
Aug 16 Stochastic Reached Oversold Weakness 0.09%
Aug 16 Oversold Stochastic Weakness 0.09%
Aug 14 180 Bearish Setup Bearish Swing Setup -3.94%
Aug 14 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -3.94%
Aug 14 Outside Day Range Expansion -3.94%
Aug 13 Wide Bands Range Expansion -8.47%
Aug 13 Oversold Stochastic Weakness -8.47%
Aug 10 Inside Day Range Contraction -4.49%

Older signals for FLXN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Flexion Therapeutics, Inc. focuses on the development and commercialization of anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. Its lead product candidate includes FX006, an intra-articular, sustained-release triamcinolone acetonide, which has completed a Phase 2b dose-ranging clinical trial to treat moderate to severe osteoarthritis (OA) pain. The company is also developing FX007, a preclinical, small-molecule TrkA receptor antagonist to address post-operative pain; and FX005, an intra-articular, sustained-release p38 MAP kinase inhibitor, which has completed a Phase 2a clinical trial to treat end-stage OA patients. Flexion Therapeutics, Inc. was founded in 2007 and is headquartered in Burlington, Massachusetts.
Is FLXN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 32.25
52 Week Low 19.06
Average Volume 458,276
200-Day Moving Average 24.9835
50-Day Moving Average 25.438
20-Day Moving Average 23.5735
10-Day Moving Average 22.59
Average True Range 1.2217
ADX 27.54
+DI 13.0157
-DI 29.5071
Chandelier Exit (Long, 3 ATRs ) 24.0649
Chandelier Exit (Short, 3 ATRs ) 24.4851
Upper Bollinger Band 26.7183
Lower Bollinger Band 20.4287
Percent B (%b) 0.24
BandWidth 26.680807
MACD Line -1.0434
MACD Signal Line -0.9507
MACD Histogram -0.0927
Fundamentals Value
Market Cap 699.68 Million
Num Shares 31.9 Million
EPS -3.11
Price-to-Earnings (P/E) Ratio -7.05
Price-to-Sales 0.00
Price-to-Book 3.08
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 23.24
Resistance 3 (R3) 23.15 22.64 23.02
Resistance 2 (R2) 22.64 22.30 22.68 22.94
Resistance 1 (R1) 22.28 22.10 22.46 22.37 22.87
Pivot Point 21.77 21.77 21.86 21.81 21.77
Support 1 (S1) 21.41 21.43 21.59 21.50 20.99
Support 2 (S2) 20.90 21.23 20.94 20.92
Support 3 (S3) 20.54 20.90 20.84
Support 4 (S4) 20.63